Oxygen Atomizing Inhalation of EGCG in the Treatment Interstitial Pneumonia in Cancer Patients
Clinical trial NCT05758571 · UNKNOWN
Trial details
- NCT number
- NCT05758571
- Sponsor
- Shandong Cancer Hospital and Institute
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-05
- Primary completion
- 2023-12-31
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.